Omeros Corporation (OMER) Financial Statements (2025 and earlier)

Company Profile

Business Address 201 ELLIOTT AVENUE WEST
SEATTLE, WA 98119
State of Incorp. WA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:90,100171,800194,900157,300134,95360,800
Cash and cash equivalent3,4007,10511,009100,80810,5013,084
Short-term investments86,732164,743183,90956,458124,45257,704
Other undisclosed cash, cash equivalents, and short-term investments(32)(48)(18)34 12
Receivables7,7398,096213,22138,1553,84135,185
Inventory, net of allowances, customer advances and progress billings     1,3551,147
Inventory     1,3551,147
Other undisclosed current assets36,28138,00235,11552,43411,1366,613
Total current assets:134,120217,898443,236247,889151,285103,745
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization 2,025 9451,009  
Operating lease, right-of-use asset14,96118,63121,76228,27625,52627,082
Property, plant and equipment2,6781,950  10,1983,829
Prepaid expense    676251,159
Restricted cash and investments1,0541,0541,0541,0541,0551,154
Other undisclosed noncurrent assets122,241138,736123,972140,973(7,647) 
Total noncurrent assets:142,959160,371147,733171,37929,75733,224
TOTAL ASSETS:277,079378,269590,969419,268181,042136,969
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities31,91039,58036,54046,83432,95451,955
Taxes payable300  
Accounts payable5,9057,7125,98913,4004,1995,328
Accrued liabilities26,00531,86830,55133,13428,75546,627
Debt21,732 94,8036481,0423,504
Financial instruments subject to mandatory redemption, settlement terms, share value, amount      
Other undisclosed current liabilities25,88413,7365,0404,3072,740 
Total current liabilities:79,52653,316136,38351,78936,73655,459
Noncurrent Liabilities
Long-term debt and lease obligation167,825213,155221,361342,584236,288190,531
Long-term debt, excluding current maturities166,583213,155220,906313,458236,288158,213
Finance lease, liability 1,242 455315 1,546
Liabilities, other than long-term debt16,7252,08822,4151,115  
Accounts payable and accrued liabilities4,5012,0884441,115  
Operating lease, liability 12,224 21,97128,811 30,772
Total noncurrent liabilities:184,550215,243243,776343,699236,288190,531
Total liabilities:264,076268,559380,159395,488273,024245,990
Equity
Equity, attributable to parent(182,609)(24,983)85,68423,780(120,752)(109,021)
Common stock580611628626616542
Additional paid in capital727,156727,936720,773706,288751,304625,048
Accumulated deficit(910,345)(753,530)(635,717)(683,134)(872,672)(734,611)
Total equity:(182,609)(24,983)85,68423,780(120,752)(109,021)
Other undisclosed liabilities and equity195,612134,693125,126 28,770 
TOTAL LIABILITIES AND EQUITY:277,079378,269590,969419,268181,042136,969

Income Statement (P&L) ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues1,5891,5001,7551,77673,813111,805
Sublease income1,5891,5001,7551,7761,300913
Cost of revenue
(Cost of Product and Service Sold)
     (902)(865)
Gross profit:1,5891,5001,7551,77672,911110,940
Operating expenses(169,258)(164,530)(163,389)(173,617)(183,512)(174,322)
Other undisclosed operating loss(1,589)(1,500)(1,755)(1,776)  
Operating loss:(169,258)(164,530)(163,389)(173,617)(110,601)(63,382)
Nonoperating income
(Other Nonoperating income)
    1,7406541,553
Interest and debt expense(24,675)(26,732)(22,702)(19,669)(40,125)(22,657)
Loss from continuing operations before equity method investments, income taxes:(193,933)(191,262)(186,091)(191,546)(150,072)(84,486)
Other undisclosed income from continuing operations before income taxes   4,062   
Loss from continuing operations before income taxes:(193,933)(191,262)(182,029)(191,546)(150,072)(84,486)
Income tax benefit     12,011 
Loss from continuing operations:(193,933)(191,262)(182,029)(191,546)(138,061)(84,486)
Loss before gain (loss) on sale of properties:(191,546)(138,061)(84,486)
Loss from discontinued operations   (3,952)   
Other undisclosed net income   233,398385,781  
Net income (loss):(193,933)(191,262)47,417194,235(138,061)(84,486)
Other undisclosed net income attributable to parent37,11873,449    
Net income (loss) available to common stockholders, diluted:(156,815)(117,813)47,417194,235(138,061)(84,486)

Comprehensive Income ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):(193,933)(191,262)47,417194,235(138,061)(84,486)
Comprehensive income (loss), net of tax, attributable to parent:(193,933)(191,262)47,417194,235(138,061)(84,486)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: